T. Mota

发表

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

M. Ostrowski, R. Lynch, R. B. Jones, 2021, Nature communications.

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

M. Ostrowski, R. Lynch, R. B. Jones, 2020, Nature Communications.

Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins

P. Bieniasz, R. B. Jones, Trinity Zang, 2022, bioRxiv.

A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies

A. Perelson, D. Irvine, B. Walker, 2020, The Journal of experimental medicine.

HIV integration and the establishment of latency in CCL19-treated resting CD4+ T cells require activation of NF-κB

M. Churchill, S. Lewin, J. Mak, 2016, Retrovirology.

Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins

P. Bieniasz, R. B. Jones, J. Boucau, 2022, Proceedings of the National Academy of Sciences of the United States of America.

ExVivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

M. Churchill, S. Lewin, S. Wesselingh, 2014 .

Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.

R. Apps, D. Nixon, R. B. Jones, 2019, AIDS research and human retroviruses.

HIV latency reversing agents act through Tat post translational modifications

S. Lewin, D. Purcell, G. Khoury, 2018, Retrovirology.

Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro

S. Lewin, P. Cameron, K. Cheong, 2016, PloS one.

Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs

C. Kovacs, R. B. Jones, A. Bosque, 2021, Journal of virology.

Latency reversing agents affect HIV RNA splicing

T. Mota, 2017 .

Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion

S. Migueles, W. Hwang, G. Nunnari, 2019, Nature Communications.

Have Cells Harboring the HIV Reservoir Been Immunoedited?

S. Lipkin, R. B. Jones, Chao Wang, 2019, Front. Immunol..

Evidence that CD32a does not mark the HIV-1 latent reservoir

R. Apps, D. Nixon, M. Ackerman, 2018, Nature.

HLA-C downregulation by HIV-1 adapts to host HLA genotype

M. Carrington, Jeffrey N. Martin, R. Apps, 2018, PLoS pathogens.

Differentiating founder and chronic HIV envelope sequences

R. Center, D. Purcell, A. Kelleher, 2017, PloS one.

Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission

J. McCaw, R. Center, D. Purcell, 2012, Retrovirology.

Immunological approaches to HIV cure.

R. B. Jones, T. Mota, A. Ward, 2020, Seminars in immunology.

BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo.

C. Kovacs, C. Bollard, R. B. Jones, 2020, The Journal of clinical investigation.

Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

M. Churchill, S. Lewin, S. Wesselingh, 2014, PloS one.

BCL-2 Antagonism Sensitizes CTL-Resistant HIV Reservoirs to Elimination Ex Vivo

C. Bollard, R. B. Jones, W. Hardy, 2019, SSRN Electronic Journal.

Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal

C. Kovacs, J. Safrit, A. Danesh, 2020, Journal of Virology.

Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells

S. Lewin, P. Cameron, T. Mota, 2018, The Journal of Immunology.

HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

J. Mellors, R. Bosch, A. Danesh, 2021, JCI insight.

Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion

S. Migueles, W. Hwang, G. Nunnari, 2019, Nature Communications.

Evidence that CD32a does not mark the HIV-1 latent reservoir

R. Apps, D. Nixon, M. Ackerman, 2018, Nature.

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting

R. B. Jones, T. Mota, R. Brad Jones, 2019, Front. Immunol..

Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs

R. Lynch, E. Connick, R. B. Jones, 2019, Journal of Virology.

HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy

J. Mellors, R. Bosch, A. Danesh, 2020 .

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

S. Lewin, D. Purcell, H. Prince, 2017, AIDS.

CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness.

Hong Wang, R. Sékaly, G. Silvestri, 2023, Immunity.

Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir

R. Apps, D. Nixon, A. Tsibris, 2018, Nature.

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

J. Joy, R. B. Jones, Z. Brumme, 2023, bioRxiv.